Healthcare Progress Is Becoming a Standards-Governed Interoperability Business
Not every important healthcare development arrives as a new drug approval or a dramatic clinical-data release. Sometimes the real bottleneck…
Category: Healthcare
Pharmacy Software Is Starting to Look Like Healthcare Infrastructure
One of the most overlooked healthcare developments of the last forty-eight hours came not from a drug trial, a reimbursement…
Radiopharma Is Becoming a Registration-Geography Business
The most interesting biotech development of the last forty-eight hours is not a dramatic efficacy surprise or another acquisition headline.…
Alzheimer’s Competition Is Moving Into the Home
The most interesting biotech development of the last forty-eight hours is not a new mechanism in early discovery or a…
The Data Are Early, but the Strategy Is Bold
In biotech, investors often overreact to early efficacy hints and underappreciate the strategy hiding underneath them. The more interesting July…
The Decentralized Intelligence Layer: How BioLayer Is Rewiring the Biotech Ecosystem
The global biotech ecosystem is currently living through a critical data paradox. Researchers have unprecedented access to high-resolution biological information…
Clinical-Trial Speed Is Becoming a National Biotech Asset
Biotech policy has spent the last several years talking as if national competitiveness were mainly a question of patents, subsidies,…
Beyond the Scale: What GLP-1 Drugs Are Really Doing to Your Body
Ozempic and Wegovy have become household names for weight loss, but a wave of new research reveals they are reshaping…
The Unraveling of the Managed Care Model: How UnitedHealth’s Crisis is Reshaping the Insurance Landscape
As federal investigations, state lawsuits, and bipartisan pushback against AI-driven prior authorization converge, the health insurance industry faces a profound…